Related Articles
Prognostic utility of fluorescence in situ hybridization for determining HER2 gene amplification in breast cancer
HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer.
Quantitative assessment of HER2/neu expression by real-time PCR and fluorescent in situ hybridization analysis in low-grade osteosarcoma
Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer
Cox-2 and Her2/neu co-expression in invasive bladder cancer